No difference in effectiveness of 8 vs 12 weeks of ledipasvir and sofosbuvir for treatment of hepatitis C in black patients

Marcus JL, Hurley LB, Chamberland S. No difference in effectiveness of 8 vs 12 weeks of ledipasvir and sofosbuvir for treatment of hepatitis C in black patients. Clin Gastroenterol Hepatol. 2018;16(6):927-935.

Publication Type:

Journal Article

Authors:

Marcus, JL; Hurley, LB; Chamberland, S

Source:

Clin Gastroenterol Hepatol, Volume 16, Issue 6, p.927-935 (2018)

Cited On:

Export Citation:
RIS Format
Top